Samuel Onuoha, MD, currently serves as the Medical Director of Hematology & Oncology at ICON plc since May 2022. Prior to this role, Samuel worked as a Medical Science Liaison at IQVIA from November 2019 to October 2020, and as an Oncology Senior Medical Science Liaison for The Janssen Pharmaceutical Companies of Johnson & Johnson from November 2020 to August 2021. Additionally, Samuel was a Physician and Principal Investigator at Peninsula Hospital from November 2010 to October 2019, and a Medical Advisor/Medical Monitor in Hematology & Oncology at Sanofi from August 2021 to May 2022. Medical education includes a Medical Internship at Aminu Kano Teaching Hospital and specialized training in Hematology/Oncology at Peninsula Hospital.
This person is not in the org chart
This person is not in any teams
This person is not in any offices